Clement F., Belleville S., Gauthier S. (2008). Cognitive complaint in mild cognitive impairment and Alzheimer's disease, J Int Neuropsychol Soc, 14(2), 222-32.

Cortese L., Caligiuri M. P., Williams S., Schieldrop P., Manchanda R., Malla A., Harricharan R. (2008). Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia, J Clin Psychopharmacol, 28(1), 69-73.

Engert V., Pruessner J. (2008). Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate, Curr Neuropharmacol, 6(4), 322-8.

Erkinjuntti T., Gauthier S., Bullock R., Kurz A., Hammond G., Schwalen S., Zhu Y., Brashear R. (2008). Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6), J Psychopharmacol.

Fiocco A. J., Poirier J., Joober R., Nair N., Lupien S. J. (2008). Acute and long-term associations between ApoE genetic polymorphism, cortisol levels, and declarative memory performance in older adults, Psychoneuroendocrinology, 33(5), 625-33.

Fortin M., Voss P., Lord C., Lassonde M., Pruessner J., Saint-Amour D., Rainville C., Lepore F. (2008). Wayfinding in the blind: larger hippocampal volume and supranormal spatial navigation, Brain.

Frey B. N., Rosa-Neto P., Lubarsky S., Diksic M. (2008). Correlation between serotonin synthesis and 5-HT1A receptor binding in the living human brain: a combined alpha-[11C]MT and [18F]MPPF positron emission tomography study, Neuroimage, 42(2), 850-7.

Gauthier S. (2008). Editorial: The PLASA Study, J Nutr Health Aging, 12(4), 262.

Gauthier S. (2008). Editorial : clinical trials and aging section, J Nutr Health Aging, 12(3), 193.

Gauthier S. (2008). Symptomatic therapeutic aspects in Alzheimer's disease, Handb Clin Neurol, 89, 269-71.

Gauthier S., Dubois B., Feldman H., Scheltens P. (2008). Revised research diagnostic criteria for Alzheimer's disease, Lancet Neurol, 7(8), 668-70.

Gauthier S., Loft H., Cummings J. (2008). Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis, Int J Geriatr Psychiatry, 23(5), 537-545.

Gauthier S., Poirier J. (2008). Current and future management of Alzheimer's disease, Alzheimers Dement, 4(1 Suppl 1), S48-50.

Goutagny R., Manseau F., Jackson J., Danik M., Williams S. (2008). In vitro activation of the medial septum-Diagonal band complex generates atropine-sensitive and atropine-resistant hippocampal theta rhythm: An investigation using a complete septohippocampal preparation, Hippocampus.

Gras C., Amilhon B., Lepicard E. M., Poirel O., Vinatier J., Herbin M., Dumas S., Tzavara E. T., Wade M. R., Nomikos G. G., Hanoun N., Saurini F., Kemel M. L., Gasnier B., Giros B., El Mestikawy S. (2008). The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone, Nat Neurosci, 11(3), 292-300.

Hay D. L., Poyner D. R., Quirion R. (2008). International Union of Pharmacology. LXIX. Status of the calcitonin gene-related peptide subtype 2 receptor, Pharmacol Rev, 60(2), 143-5.

Hsiung G. Y., Alipour S., Jacova C., Grand J., Gauthier S., Black S. E., Bouchard R. W., Kertesz A., Loy-English I., Hogan D. B., Rockwood K., Feldman H. H. (2008). Transition from Cognitively Impaired Not Demented to Alzheimer's Disease: An Analysis of Changes in Functional Abilities in a Dementia Clinic Cohort, Dement Geriatr Cogn Disord, 25(6), 483-490.

Hudon C., Belleville S., Gauthier S. (2008). The association between depressive and cognitive symptoms in amnestic mild cognitive impairment, Int Psychogeriatr, 1-14.

Huh C. Y., Danik M., Manseau F., Trudeau L. E., Williams S. (2008). Chronic exposure to nerve growth factor increases acetylcholine and glutamate release from cholinergic neurons of the rat medial septum and diagonal band of broca via mechanisms mediated by p75(NTR), J Neurosci, 28(6), 1404-9.

Kashani A., Lepicard E., Poirel O., Videau C., David J. P., Fallet-Bianco C., Simon A., Delacourte A., Giros B., Epelbaum J., Betancur C., El Mestikawy S. (2008). Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease, Neurobiol Aging, 29(11), 1619-30.